Overview

Vybion, Inc. is a private biotechnology company based in the United States, dedicated to developing innovative therapies for neurodegenerative and genetic disorders. The company's proprietary technology focuses on creating novel peptide therapies targeting challenging diseases.

Therapeutic areas

Neurodegenerative DisordersGenetic Disorders

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Vybion, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.